![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Richard Furman, MD
ALL Specialist
-min_30b108db-ffda-4f68-a776-427bed864ef4.jpg?alt=media&token=7fae0fe4-f10f-4e19-92af-f98b9353e954)
Clinical Expertise
- Leukemia, Acute Lymphoblastic (ALL)
- Lymphoma
About
Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicine and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology. His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.
Location
Weill Cornell Medical Center: 425 E 61st St 8th floor, New York, NY 10065, USA
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2024 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811